Jamieson Wellness (TSE:JWEL) Stock Rating Lowered by National Bank Financial

Jamieson Wellness (TSE:JWEL) was downgraded by analysts at National Bank Financial from an “outperform” rating to a “tender” rating in a report issued on Monday,BayStreet.CA reports. They currently have a C$45.75 price objective on the stock, down from their previous price objective of C$51.00. National Bank Financial’s price target points to a potential upside of 0.44% from the company’s current price.

JWEL has been the topic of a number of other research reports. Canaccord Genuity Group cut shares of Jamieson Wellness from a “buy” rating to a “hold” rating and upped their target price for the company from C$44.50 to C$45.75 in a research note on Monday, August 10th. Stifel Nicolaus lowered Jamieson Wellness from a “buy” rating to a “hold” rating and upped their price objective for the company from C$45.00 to C$45.75 in a research note on Friday, August 7th. Canadian Imperial Bank of Commerce cut Jamieson Wellness from an “outperformer” rating to a “tender” rating and increased their target price for the stock from C$44.00 to C$45.75 in a report on Friday, August 7th. Royal Bank Of Canada downgraded Jamieson Wellness from an “outperform” rating to a “sector perform” rating and cut their target price for the stock from C$46.00 to C$45.75 in a research report on Monday, August 10th. Finally, TD lowered Jamieson Wellness from a “buy” rating to a “hold” rating and boosted their price target for the company from C$48.00 to C$49.00 in a research note on Monday, August 10th. One equities research analyst has rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Jamieson Wellness currently has a consensus rating of “Hold” and a consensus price target of C$46.54.

Jamieson Wellness Stock Performance

JWEL stock remained flat at C$45.55 during midday trading on Monday. The company had a trading volume of 210,876 shares, compared to its average volume of 117,566. The firm has a market capitalization of C$1.89 billion, a price-to-earnings ratio of 24.89 and a beta of 1.48. Jamieson Wellness has a 52-week low of C$32.54 and a 52-week high of C$45.76. The stock’s 50 day simple moving average is C$42.55 and its 200-day simple moving average is C$37.82. The company has a quick ratio of 1.08, a current ratio of 3.41 and a debt-to-equity ratio of 93.69.

Jamieson Wellness (TSE:JWEL) last announced its quarterly earnings results on Thursday, August 6th. The company reported C$0.46 earnings per share (EPS) for the quarter. Jamieson Wellness had a net margin of 8.92% and a return on equity of 15.93%. The firm had revenue of C$233.84 million for the quarter. On average, equities analysts forecast that Jamieson Wellness will post 2.1438892 EPS for the current year.

About Jamieson Wellness

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.